This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

Advances in Cell Based Screening - Bi-annual Conference

Organised by the European Laboratory Research & Innovation Group (ELRIG)

10–11 May 2017

Abstracts deadline: 10 Apr 2017

Registration deadline: 12 May 2017

Astrazeneca, Gotthenburg, Sweden - View map

  • Overview
The 2nd ELRIG bi-annual conference on Advances in Cell Based Screening in Drug Discovery will be held on 10 and 11 May 2017 at AstraZeneca in Gothenburg. This interactive 2-day event will host leading scientists from academia and industry, coming together to discuss the latest developments in cell based screening in drug discovery.

The program for this ELRIG meeting has been developed to expand scientific horizons in key topic areas such as advanced cell models, applied omics, assays/methods exploring mode of action, phenotypic screening, target deconvolution, and much more. Speakers from leading laboratories, both academic and industrial, will present and discuss the latest updates and advances in cellular systems and drug discovery platforms. Throughout the course of the two day conference, you will get an exclusive opportunity to network and be involved in inspiring and interesting discussions with scientists and researchers from the pharmaceutical, academic and vendor communities.

There will be opportunities for scientists to network and discuss challenges and solutions relating to current and breakthrough assay technologies and provide a platform to assess the true value and impact of new and innovative approaches to cell based drug discovery.

View here for registration and event information.

Contact ELRIG for further details. 

Individuals interested in registering or about to travel to any meetings and events outside the UK are encouraged to check the Foreign & Commonwealth Office travel advice, or their government’s equivalent guidance.